Related Experiment Video
Updated: Apr 12, 2026

Rapid Freezing using Sandwich Freezing Device for Good Ultrastructural Preservation of Biological Specimens in Electron Microscopy
Published on: July 19, 2021
Kodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review
Debadulal Biswal1, Manisa Sahu2, Asmita Mahajan3
1Senior Registrar, Department of Medical Oncology, S L Raheja Hospital , Mahim (W), Mumbai, Maharashtra, India .
Abstract:
Kodameae ohmeri is an emerging pathogen in various types of infections. Most infections are seen in patients with compromised immunity like cancer patients. Few cases of neonatal infections due to K. ohmeri have been reported earlier in premature neonates with fatal outcomes. We report two cases of fungemia; the first case was a patient with hematological malignancy, who complained of fever spikes and grew K. ohmeri in blood despite prophylactic voriconazole therapy. The second case was in a mature neonate, who developed respiratory distress and features of sepsis two days after birth, multiple blood cultures were positive for K. ohmeri. Both the patients responded well to Amphotericin B. Repeat blood cultures were sterile and patients were discharged. K. ohmeri is an unusual and emerging fungal pathogen of late an increasing number of cases of fungemia, funguria, endocarditis, peritonitis and wound infections due to the same are being reported. Some occur in immunocompromised patients and some inapparently immunocompetent patients, neonates with an inclination for preterm babies. We report two case of fungemia, one with lymphoma and the second in a neonate.
Insights
Kodameae ohmeri is an emerging fungal pathogen causing infections, particularly in immunocompromised individuals and neonates. Early diagnosis and treatment with Amphotericin B were effective in two reported fungemia cases.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Kodameae ohmeri (K. ohmeri) is an emerging fungal pathogen causing diverse infections.
- Infections are frequently observed in immunocompromised patients, such as those with cancer.
- Neonatal infections, especially in premature infants, have been reported with severe outcomes.
Observation:
- Two cases of fungemia caused by K. ohmeri are presented.
- The first case involved a patient with hematological malignancy experiencing fever spikes despite antifungal prophylaxis.
- The second case involved a neonate presenting with respiratory distress and sepsis post-birth.
Findings:
- Both patients, despite different risk factors, developed K. ohmeri fungemia.
- Prompt treatment with Amphotericin B led to successful clinical recovery and sterile blood cultures in both cases.
- K. ohmeri demonstrates increasing prevalence in various infections, affecting both immunocompromised and apparently immunocompetent individuals, including neonates.
Implications:
- This study highlights K. ohmeri as a significant emerging pathogen requiring clinical vigilance.
- Effective treatment options, such as Amphotericin B, are crucial for managing K. ohmeri fungemia.
- Further research is needed to understand the epidemiology and optimal management strategies for K. ohmeri infections.
Related Concept Videos
Yeast Signaling
Fungal Phylum Ascomycota
Microbes in Beverage Production
Microbes in the Production of Fermented Foods
Bioreactor Controls-III
Fungal Group Zygomycota

